Haas et al.’s study [13] found no difference in plasma level of BDNF between the antidepressant-naive FM group, patients receiving analgesic doses of tricyclic antidepressants and patients with antidepressants at therapeutic doses for depression. The gene discussed is BDNF; the disease is depressive symptom measurement.